Ningxia Zhongke Biotechnology Co (SHSE:600165) Total Liabilities : ¥2,490.3 Mil (As of Sep. 2023)

View and export this data going back to 1998. Start your Free Trial

What is Ningxia Zhongke Biotechnology Co Total Liabilities?

Ningxia Zhongke Biotechnology Co's Total Liabilities for the quarter that ended in Sep. 2023 was ¥2,490.3 Mil.

Ningxia Zhongke Biotechnology Co's quarterly Total Liabilities increased from Mar. 2023 (¥2,388.65 Mil) to Jun. 2023 (¥2,408.71 Mil) and increased from Jun. 2023 (¥2,408.71 Mil) to Sep. 2023 (¥2,490.35 Mil).

Ningxia Zhongke Biotechnology Co's annual Total Liabilities increased from Dec. 2020 (¥2,064.17 Mil) to Dec. 2021 (¥2,242.04 Mil) and increased from Dec. 2021 (¥2,242.04 Mil) to Dec. 2022 (¥2,384.62 Mil).

Ningxia Zhongke Biotechnology Co Total Liabilities Historical Data

The historical data trend for Ningxia Zhongke Biotechnology Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ningxia Zhongke Biotechnology Co Total Liabilities Chart

Ningxia Zhongke Biotechnology Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Liabilities

Get a 7-Day Free Trial

1,187.50

1,322.61

2,064.17

2,242.04

2,384.62

Ningxia Zhongke Biotechnology Co Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Total Liabilities	Get a 7-Day Free Trial															2,170.60	2,384.62	2,388.65	2,408.71	2,490.35

Ningxia Zhongke Biotechnology Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Ningxia Zhongke Biotechnology Co's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1566.516	+	(283.028	+	535.073
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	2,384.6

Total Liabilities	=	Total Assets (A: Dec. 2022 )	-	Total Equity (A: Dec. 2022 )
	=	3278.698	-	894.081
	=	2,384.6

Ningxia Zhongke Biotechnology Co's Total Liabilities for the quarter that ended in Sep. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1713.586	+	(232.784	+	543.977
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	2,490.3

Total Liabilities	=	Total Assets (Q: Sep. 2023 )	-	Total Equity (Q: Sep. 2023 )
	=	3136.576	-	646.23
	=	2,490.3

Ningxia Zhongke Biotechnology Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Ningxia Zhongke Biotechnology Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Ningxia Zhongke Biotechnology Co (SHSE:600165) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Ningxia Zhongke Biotechnology Co Ltd (SHSE:600165) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Hebin Street, Ningxia Hui Autonomous Region, Huinong District, Shizuishan, CHN, 750002

Website

http://www.nxhengli.com.cn

Ningxia Zhongke Biotechnology Co Ltd is engaged in the production and sales of activated carbon products, preparation and storage of stem cells, trade and other businesses, as well as lauric acid.

Ningxia Zhongke Biotechnology Co (SHSE:600165) Headlines

No Headlines